Fatty acid synthase (FASN) is the biosynthetic enzyme responsible for the endogenous synthesis of fatty acids. It is downregulated in most normal cells, except in lipogenic tissues such as liver, lactating breast, fetal lung, and adipose tissue. Conversely, several human cancers, including head and neck squamous cell carcinomas (HNSCC), overexpress FASN, which has been associated with poor prognosis and recently suggested as a metabolic oncoprotein. Orlistat is an irreversible inhibitor of FASN activity with cytotoxic properties on several cancer cell lines that inhibits tumor progression and metastasis in prostate cancer xenografts and experimental melanomas, respectively. To explore whether the inhibition of FASN could impact oral tongue squamous cell carcinoma (OTSCC) metastatic spread, an orthotopic model was developed by the implantation of SCC-9 ZsGreen LN-1 cells into the tongue of BALB/c nude mice. These cells were isolated through in vivo selection, show a more invasive behavior in vitro than the parental cells, and generate orthotopic tumors that spontaneously metastasize to cervical lymph nodes in 10 to 15 days only. SCC-9 ZsGreen LN-1 cells also exhibit enhanced production of MMP-2, ERBB2, and CDH2. The treatment with orlistat reduced proliferation and migration, promoted apoptosis, and stimulated the secretion of VEGFA165b by SCC-9 ZsGreen LN-1 cells. In vivo, the drug was able to decrease both the volume and proliferation indexes of the tongue orthotopic tumors and, importantly, reduced the number of metastatic cervical lymph nodes by 43%. These results suggest that FASN is a potential molecular target for the chemotherapy of patients with OTSCC. © 2013 AACR.133585595Dwivedi, R.C., Kazi, R.A., Agrawal, N., Nutting, C.M., Clarke, P.M., Kerawala, C.J., Evaluation of speech outcomes following treatment of oral and pharyngeal cancers (2009) Cancer Treat Rev, 35, pp. 417-424Warnakulasuriya, S., Global epidemiology of oral and oropharyngeal cancer (2009) Oral Oncol, 45, pp. 309-316Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Thun, M.J., Cancer statistics, 2009 (2009) CA Cancer J Clin, 9, pp. 225-249Scully, C., Bagan, J., Oral squamous cell carcinoma: Overview of current understanding of aetiopathogenesis and clinical implications (2009) Oral Dis, 15, pp. 388-399Sano, D., Myers, J.N., Metastasis of squamous cell carcinoma of the oral tongue (2007) Cancer and Metastasis Reviews, 26 (3-4), pp. 645-662. , DOI 10.1007/s10555-007-9082-y, Forty Years of Metastasis Research: A Tribute to Dr. Isaiah J. FidlerLeemans, C.R., Tiwari, R., Nauta, J.J.P., Van Der, W.I., Snow, G.B., Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor (1994) Cancer, 73 (1), pp. 187-190. , DOI 10.1002/1097-0142(19940101)73:1<187::AID-CNCR2Forastiere, A., Koch, W., Trotti, A., Sidransky, D., Head and neck cancer (2001) N Engl J Med, 345, pp. 1890-1900Kuriakose, M.A., Trivedi, N.P., Sentinel node biopsy in head and neck squamous cell carcinoma (2009) Curr Opin Otolaryngol Head Neck Surg, 17, pp. 100-110Vokes, E.E., Weichselbaum, R.R., Lippman, S.M., Hong, W.K., Head and neck cancer (1993) N Engl J Med, 328, pp. 184-194Clark, J.R., Naranjo, N., Franklin, J.H., De Almeida, J., Gullane, P.J., Established prognostic variables in N0 oral carcinoma (2006) Otolaryngology - Head and Neck Surgery, 135 (5), pp. 748-753. , DOI 10.1016/j.otohns.2006.05.751, PII S0194599806026301Rusthoven, K., Ballonoff, A., Raben, D., Chen, C., Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma (2008) Cancer, 112, pp. 345-351Bello, I.O., Soini, Y., Salo, T., Prognostic evaluation of oral tongue cancer: Means, markers and perspectives (I) (2010) Oral Oncol, 46, pp. 630-635Priante, A.V., Castilho, E.C., Kowalski, L.P., Second primary tumors in patients with head and neck cancer (2011) Curr Oncol Rep, 13, pp. 132-137Baron, A., Migita, T., Tang, D., Loda, M., Fatty acid synthase: A metabolic oncogene in prostate cancer? (2004) J Cell Biochem, 91, pp. 47-53Liu, H., Liu, J.-Y., Wu, X., Zhang, J.T., Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker (2010) Int J Biochem Mol Biol, 1, pp. 69-89Kuhajda, F.P., Fatty acid synthase and cancer: New application of an old pathway (2006) Cancer Res, 66, pp. 5977-5980Agostini, M., Silva, S.D., Zecchin, K.G., Coletta, R.D., Jorge, J., Loda, M., Graner, E., Fatty acid synthase is required for the proliferation of human oral squamous carcinoma cells (2004) Oral Oncology, 40 (7), pp. 728-735. , DOI 10.1016/j.oraloncology.2004.01.011, PII S1368837504000272Silva, S.D., Agostini, M., Nishimoto, I.N., Coletta, R.D., Alves, F.A., Lopes, M.A., Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study (2004) Oral Oncol, 40, pp. 688-696Silva, S.D., Cunha, I.W., Rangel, A.L., Jorge, J., Zecchin, K.G., Agostini, M., Differential expression of fatty acid synthase (FAS) and ErbB2 in nonmalignant and malignant oral keratinocytes (2008) Virchows Arch, 453, pp. 57-67Silva, S.D., Perez, D.E., Nishimoto, I.N., Alves, F.A., Pinto, C.A.L., Kowalski, L.P., Graner, E., Fatty acid synthase expression in squamous cell carcinoma of the tongue: Clinicopathological findings (2008) Oral Diseases, 14 (4), pp. 376-382. , DOI 10.1111/j.1601-0825.2007.01395.xDa Silva, S.D., Cunha, I.W., Nishimoto, I.N., Soares, F.A., Carraro, D.M., Kowalski, L.P., Clinicopathological significance of ubiquitin-specific protease 2 (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas (2009) Oral Oncol, 45, pp. e134-e139Vazquez-Martin, A., Colomer, R., Brunet, J., Lupu, R., Menendez, J.A., Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells (2008) Cell Proliferation, 41 (1), pp. 59-85. , DOI 10.1111/j.1365-2184.2007.00498.xMigita, T., Ruiz, S., Fornari, A., Fiorentino, M., Priolo, C., Zadra, G., Fatty acid synthase: A metabolic enzyme and candidate oncogene in prostate cancer (2009) J Natl Cancer Inst, 101, pp. 519-532Pizer, E.S., Wood, F.D., Heine, H.S., Romantsev, F.E., Pasternack, G.R., Kuhajda, F.P., Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer (1996) Cancer Research, 56 (6), pp. 1189-1193Pizer, E.S., Chrest, F.J., DiGiuseppe, J.A., Han, W.F., Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines (1998) Cancer Research, 58 (20), pp. 4611-4615Kridel, S.J., Axelrod, F., Rozenkrantz, N., Smith, J.W., Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity (2004) Cancer Res, 64, pp. 2070-2075Menendez, J.A., Vellon, L., Lupu, R., Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: Blockade of cell cycle progression, promotion of apoptotic cell death and PEA3 mediated transcriptional repression of Her2/neu (erbB-2) oncogene (2005) Ann Oncol, 16, pp. 1253-1267Liu, H., Liu, Y., Zhang, J.-T., A new mechanism of drug resistance in breast cancer cells: Fatty acid synthase overexpression-mediated palmitate overproduction (2008) Molecular Cancer Therapeutics, 7 (2), pp. 263-270. , http://mct.aacrjournals.org/cgi/reprint/7/2/263, DOI 10.1158/1535-7163.MCT-07-0445Carvalho, M.A., Zecchin, K.G., Seguin, F., Bastos, D.C., Agostini, M., Rangel, A.L., Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model (2008) Int J Cancer, 123, pp. 2557-2565Zecchin, K.G., Alberici, L.C., Riccio, M.F., Eberlin, M.N., Vercesi, A.E., Graner, E., Visualizing inhibition of fatty acid synthase through mass spectrometric analysis of mitochondria from melanoma cells (2011) Rapid Commun Mass Spectrom, 25, pp. 449-452Zecchin, K.G., Rossato, F.A., Raposo, H.F., Melo, D.R., Alberici, L.C., Oliveira, H.C., Inhibition of fatty acid synthase in melanoma cells activates the intrinsic pathway of apoptosis (2011) Lab Invest, 91, pp. 232-240Harrell, J.C., Dye, W.W., Allred, D.C., Jedlicka, P., Spoelstra, N.S., Sartorius, C.A., Horwitz, K.B., Estrogen receptor positive breast cancer metastasis: Altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes (2006) Cancer Research, 66 (18), pp. 9308-9315. , DOI 10.1158/0008-5472.CAN-06-1769Ramírez-Zacarías, J.L., Castro-Muñozledo, F., Kuri-Harcuch, W., Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O (1992) Histochemistry, 97, pp. 493-497Dole, V.P., Meinertz, H., Microdetermination of Long-chain Fatty Acids in Plasma and Tissues (1960) J Biol Chem, 235, pp. 2595-2599Knowles, L.M., Axelrod, F., Browne, C.D., Smith, J.W., A fatty acid synthase blockade induces tumor cell-cycle arrest by down-regulating Skp2 (2004) J Biol Chem, 279, pp. 30540-30545Nurmenniemi, S., Sinikumpu, T., Alahuhta, I., Salo, S., Sutinen, M., Santala, M., A novel organotypic model mimics the tumor microenvironment (2009) Am J Pathol, 175, pp. 1281-1291Yorioka, C.W., Coletta, R.D., Alves, F., Nishimoto, I.N., Kowalski, L.P., Graner, E., Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients (2002) Int J Oncol, 20, pp. 189-194Johnson, F.B., Lipids (1992) Laboratory Methods in Histotechnology, p. 177. , Prophet EB, Mills B, Arrington JB, Sobin LH, editors. Armed Forces Institute of Pathology. Washington, DCDa Silva, S.D., Ferlito, A., Takes, R.P., Brakenhoff, R.H., Valentin, M.D., Woolgar, J.A., Advances and applications of oral cancer basic research (2011) Oral Oncol, 47, pp. 783-791Menendez, J.A., Vellon, L., Lupu, R., The antiobesity drug Orlistat induces cytotoxic effects, suppresses Her-2/neu (erbB-2) oncogene overexpression, and synergistically interacts with trastuzumab (Herceptin) in chemoresistant ovarian cancer cells (2006) Int J Gynecol Cancer, 16, pp. 219-221Little, J.L., Wheeler, F.B., Fels, D.R., Koumenis, C., Kridel, S.J., Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells (2007) Cancer Res, 67, pp. 1262-1269Dowling, S., Cox, J., Cenedella, R.J., Inhibition of fatty acid synthase by Orlistat accelerates gastric tumor cell apoptosis in culture and increases survival rates in gastric tumor bearing mice in vivo (2009) Lipids, 44, pp. 489-498Deepa, P.R., Vandhana, S., Jayanthi, U., Krishnakumar, S., Therapeutic and toxicological evaluation of anti-lipogenic agents in cancer cells compared with non-neoplastic cells (2012) Basic Clin Pharmacol Toxicol, 110, pp. 494-503Gelebart, P., Zak, Z., Anand, M., Belch, A., Lai, R., Blockade of Fatty Acid synthase triggers significant apoptosis in mantle cell lymphoma (2012) PLoS ONE, 7, pp. e33738Murata, S., Yanagisawa, K., Fukunaga, K., Oda, T., Kobayashi, A., Sasaki, R., Fatty acid synthase inhibitor cerulenin suppresses liver metastasis of colon cancer in mice (2010) Cancer Sci, 101, pp. 1861-1865Zaytseva, Y.Y., Rychahou, P.G., Gulhati, P., Elliott, V.A., Mustain, W.C., O'Connor, K., Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer (2012) Cancer Res, 72, pp. 1504-1517Scott, K.E., Wheeler, F.B., Davis, A.L., Thomas, M.J., Ntambi, J.M., Seals, D.F., Metabolic regulation of invadopodia and invasion by acetyl-CoA carboxylase 1 and de novo lipogenesis (2012) PLoS ONE, 7, pp. e29761Yoshii, Y., Furukawa, T., Oyama, N., Hasegawa, Y., Kiyono, Y., Nishii, R., Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: Uptake of radiolabeled acetate as a predictor of the targeted therapy outcome (2013) PLoS ONE, 8, pp. e64570Kuemmerle, N.B., Rysman, E., Lombardo, P.S., Flanagan, A.J., Lipe, B.C., Wells, W.A., Lipoprotein lipase links dietary fat to solid tumor cell proliferation (2011) Mol Cancer Ther, 10, pp. 427-436Graner, E., Tang, D., Rossi, S., Baron, A., Migita, T., Weinstein, L.J., Lechpammer, M., Loda, M., The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer (2004) Cancer Cell, 5 (3), pp. 253-261. , DOI 10.1016/S1535-6108(04)00055-8, PII S1535610804000558Yoshimoto, M., Waki, A., Yonekura, Y., Sadato, N., Murata, T., Omata, N., Takahashi, N., Fujibayashi, Y., Characterization of acetate metabolism in tumor cells in relation to cell proliferation: Acetate metabolism in tumor cells (2001) Nuclear Medicine and Biology, 28 (2), pp. 117-122. , DOI 10.1016/S0969-8051(00)00195-5, PII S0969805100001955Browne, C.D., Hindmarsh, E.J., Smith, J.W., Inhibition of endothelial cell proliferation and angiogenesis by orlistat, a fatty acid synthase inhibitor (2006) FASEB Journal, 20 (12), pp. 2027-2035. , http://www.fasebj.org/cgi/reprint/20/12/2027.pdf, DOI 10.1096/fj.05-5404comSeguin, F., Carvalho, M.A., Bastos, D.C., Agostini, M., Zecchin, K.G., Alvarez-Flores, M.P., The fatty acid synthase (FASN) inhibitor orlistat reduces experimental metastasis and angiogenesis in B16-F10 melanomas (2012) Br J Cancer, 107, pp. 977-987Patel, V., Marsh, C.A., Dorsam, R.T., Mikelis, C.M., Masedunskas, A., Amornphimoltham, P., Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer (2011) Cancer Res, 71, pp. 7103-7112Kant, S., Kumar, A., Singh, S.M., Fatty acid synthase inhibitor orlistat induces apoptosis in T cell lymphoma: Role of cell survival regulatory molecules (2012) Biochim Biophys Acta, 1820, pp. 1764-1773Swinnen, J.V., Van Veldhoven, P.P., Timmermans, L., De Schrijver, E., Brusselmans, K., Vanderhoydonc, F., Van De, S.T., Verhoeven, G., Fatty acid synthase drives the synthesis of phospholipids partitioning into detergent-resistant membrane microdomains (2003) Biochemical and Biophysical Research Communications, 302 (4), pp. 898-903. , DOI 10.1016/S0006-291X(03)00265-1Rysman, E., Brusselmans, K., Scheys, K., Timmermans, L., Derua, R., Munck, S., De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation (2010) Cancer Res, 70, pp. 8117-8126Vandhana, S., Coral, K., Jayanthi, U., Deepa, P.R., Krishnakumar, S., Biochemical changes accompanying apoptotic cell death in retinoblastoma cancer cells treated with lipogenic enzyme inhibitors (2013) Biochim Biophys Acta, 1831, pp. 1458-1466